Peroxisomal β-oxidation and peroxisome proliferator - Activated receptor α: An adaptive metabolic system

Annual Review of Nutrition

Volumn 21, Issue , 2001, Pages 193-230

  Reddy, J K ^a   Hashimoto, T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Fatty acid oxidation; Gene knockout models; PPAR

Indexed keywords

ACETYL COENZYME A ACETYLTRANSFERASE; ACYL COENZYME A; ACYL COENZYME A DEHYDROGENASE; CYTOCHROME P450 ISOENZYME; DICARBOXYLIC ACID DERIVATIVE; HYDROGEN PEROXIDE; ICOSANOID; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROSTANOIC ACID DERIVATIVE; STEROL CARRIER PROTEIN; VERY LONG CHAIN FATTY ACID;

ANIMAL EXPERIMENT; ENERGY METABOLISM; ENZYME INDUCTION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY LIVER; GENETIC TRANSCRIPTION; LIPID METABOLISM; LIVER CANCER; MICROSOME; MITOCHONDRION; MOUSE; NONHUMAN; PEROXISOME; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; TRANSCRIPTION REGULATION;

ADAPTATION, BIOLOGICAL; ANIMALS; ENERGY METABOLISM; FATTY ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; LIPID METABOLISM, INBORN ERRORS; MICE; MICROSOMES; MITOCHONDRIA; OXIDATION-REDUCTION; PEROXISOMES; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0034939632     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.21.1.193     Document Type: Review

References (109)

1. Comparison of the stability and substrate specificity of purified peroxisomal 3-oxoacyl-CoA thiolases A and B from rat liver
2. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα)
3. Increased peroxisomal fatty acid β-oxidation and enhanced expression of peroxisome proliferator-activated receptor α in diabetic rat liver
4. PPARγ, the ultimate thrifty gene
5. Mouse models for peroxisome biogenesis disorders
6. Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very-long-chain fatty acids
7. PPARγ is required for placental, cardiac, and adipose tissue development
8. Molecular characterization of the human peroxisomal branched-chain acyl-CoA oxidase: cDNA cloning, chromosomal assignment, tissue distribution, and evidence for the absence of the protein in Zellweger syndrome
9. Molecular cloning and further characterization of rat peroxisomal trihydroxycoprostanoyl-CoA oxidase
10. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function
11. Acute hepatic failure and defective fatty acid transport: Clinical proof of a physiologic hypothesis
12. Intracellular lipid-binding proteins and their genes
13. Thiolase involved in bile acid formation
14. Cytochrome P450 and arachidonic acid bioactivation: Molecular and functional properties of the arachidonic acid monoxygenase
15. β-oxidation in glyoxysomes from castor bean endosperm
16. Peroxisomes (microbody and related particles)
17. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
18. Glu-320 and Asp-323 are determinants of the CYP4A1 hydroxylation regiospecificity and resistance to inactivation by 1-aminobenzotriazole
19. Evidence that multifunctional protein 2, and not multifunctional protein 1, is involved in the peroxisomal β-oxidation of pristanic acid
20. Further characterization of the peroxisomal 3-hydroxyacyl-CoA dehydrogenases from rat liver. Relationship between the different dehydrogenases and evidence that fatty acids and the C27-bile acids di- and trihydroxycoprostanoic acids are metabolized by separate multifunctional proteins
21. Mammalian mitochondrial β-oxidation
22. Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat
23. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase
24. Regulation of nutrient metabolism and energy expenditure
25. Metabolic and nutritional considerations in nonalcoholic fatty liver
26. Large deletion of the peroxisomal acyl-CoA oxidase gene in pseudoneonatal adrenoleukodystrophy
27. A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity
28. Mobilisation of triacylglycerol stores
29. The coregulator exchange in transcriptional functions of nuclear receptors
30. Mechanism of action of the nongenotoxic peroxisome proliferator-activator receptor α
31. Isolation, complementary DNA sequence, and regulation of rat hepatic lauric acid ω-hydroxylase (cytochrome P450LAω): Identification of new cytochrome P-450 gene family
32. Peroxisomal β-oxidation: Enzymology and molecular biology
33. Peroxisomal β-oxidation enzymes
34. Defect in peroxisome proliferator-activated receptor α-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting
35. Peroxisomal and mitochondrial fatty acid β-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor α and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype
36. Peroxisomal β-oxidation and polyunsaturated fatty acids
37. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid ω-hydroxylases
38. cDNA cloning of the human peroxisomal enoyl-CoA hydratase: 3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme and localization to chromosome 3q26.3-3q28: A free left Alu arm is inserted in the 3′ non-coding region
39. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
40. Involvement of the TRAP220 component of the TRAP/SMCC coactivator complex in embryonic development and thyroid hormone action
41. Non-alcoholic steatohepatitis: Another disease of affluence
42. Purification and properties of rat D-3-hydroxyacyl-CoA dehydratase: D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxy-acylCoA dehydrogenase bifunctional protein
43. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation
44. Aberrant oxidation of the cholesterol side chain in bile acid synthesis of sterol carrier protein-2/sterol carrier protein-x knockout mice
45. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
46. Peroxisome proliferator-activated receptor α controls the hepatic CYP4A induction adaptive response to starvation and diabetes
47. β-oxidation of fatty acids in mitochondria, peroxisomes, and bacteria: A century of continued progress
48. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug
49. Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators
50. Structure of the gene for the human 17-β-hydroxysteroid dehydrogenase type IV
51. A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
52. 2,4,6-trienoyl-CoA isomerase, a novel enzyme that functions in the β-oxidation of polyunsaturated fatty acids with conjugated double bonds
53. A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern
54. A mouse model for 56-linked adrenoleukodystrophy
55. Peroxisomal lipid degradation via β- and α-oxidation in mammals
56. Characterization of the HSD17B4 gene: D-specific multifunctional protein 2/17β-hydroxysteroid dehydrogenase IV
57. Molecular cloning and deduced amino acid sequence of nonspecific lipid transfer protein (sterol carrier protein2) of rat liver: A higher molecular mass (60 kDa) protein contains the primary sequence of nonspecific lipid transfer protein as its C-terminal part
58. Putative 10X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
59. Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (10X-ALD): Implication for therapy
60. Genes for the human mitochondrial trifunctional protein α- and β-subunits are divergently transcribed from a common promoter region
61. Structure and expression of the genes encoding peroxisomal β-oxidation enzymes
62. Peroxisome proliferator activated receptor-α expression in human liver
63. 2-enoyl-CoA isomerase, 2-enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase enzyme in rat liver
64. Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptorβ(δ)
65. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis
66. Absence of spontaneous peroxisome proliferation in enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase-deficient mouse liver. Further support for the role of fatty acyl CoA oxidase in PPARα ligand metabolism
67. Mouse steroid receptor coactivator-1 is not essential for peroxisome proliferator-activated receptor α-regulated gene expression
68. Peroxisome proliferator-activated receptors, coactivators, and downstream targets
69. Peroxisomal multifunctional enzyme of β-oxidation metabolizing D-3-hydroxyacyl-CoA esters in rat liver: Molecular cloning, expression and characterization
70. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
71. Hepatocarcinogenesis of peroxisome proliferators
72. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens
73. Peroxisome proliferator-induced pleiotropic responses: Pursuit of a phenomenon
74. Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA:hydratase3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators
75. Hepatic peroxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate
76. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans
77. Peroxisomal lipid metabolism
78. Expression cloning and characterization of a novel adipocyte long-chain fatty acid transport protein
79. Presence of three acyl-CoA oxidases in rat liver peroxisomes. An inducible fatty acyl-CoA oxidase, a noninducible fatty acyl-CoA oxidase, and a noninducible trihydroxycoprostanoyl-CoA oxidase
80. Defective peroxisomal catabolism of branched fatty acyl coenzyme A in mice lacking the sterol carder protein-2/sterol carrier protein-x gene function
81. CDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor
82. Adipogenesis and obesity: Rounding out the big picture
83. Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement
84. Structure and regulation of rat long-chain acyl-CoA synthetase
85. D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: A newly identified peroxisomal disorder
86. Identification of diazepam-binding inhibitor/acyl-CoA binding protein as a sterol regulatory element binding protein-responsive gene
87. Disorders of the mitochondria
88. Novel fatty acid β-oxidation enzymes in rat liver. II. Purification and properties of enoyl-coenzyme (CoA) hydratase/3-hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase trifunctional protein
89. Purification and properties of rat liver very-long-chain acyl-CoA synthetase
90. Molecular cloning of cDNA encoding rat very-long-chain acyl-CoA synthetase
91. Regulation of fatty acid homeostasis in cells: Novel role of leptin
92. Biochemistry of peroxisomes
93. Peroxisomal D-hydroxyacyl-CoA dehydrogenase deficiency: Resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency
94. Peroxisomal bifunctional protein deficiency revisited: Resolution of its true enzymatic and molecular basis
95. Rat pristanoyl-CoA oxidase, cDNA cloning and recognition of its C-terminal (SQL) by the peroxisomal-targeting signal 1 receptor
96. The CoA esters of 2-methyl-branched-chain fatty acids and of the bile acid intermediates di- and trihydroxycoprostanoic acids are oxidized by one single peroxisomal branched-chain acyl-CoA oxidase in human liver and kidney
97. Identification of peroxisome proliferator-responsive element upstream of the human peroxisomal fatty acylcoenzyme A oxidase gene
98. Peroxisomes, lipid metabolism, and human disease
99. Sterol carrier protein x (SCPx) is a peroxisomal branched-chain β-ketothiolase specifically reacting with 3-oxo-pristanoyl-CoA: A new, unique role for SCPx in branched-chain fatty acid metabolism in peroxisomes
100. The PPARs: From orphan receptors to drug discovery
101. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene
102. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice
103. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis
104. Isolation and characterization of peroxisome proliferator-activated receptors (PPAR) interaction protein (PRIP) as a coactivator for PPAR
105. Cloning and identification of mouse steroid receptor coactivator-1 (mSRC-1), as a coactivator of peroxisome proliferator-activated receptor γ
106. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor
107. Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality
108. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPAR γ) gene: Alternative promoter use and different splicing yield two mPPAR γ isoforms